Human liver aldehyde oxidase: differential inhibition of oxidation of charged and uncharged substrates
about
The oxidation of azaheterocycles with mammalian liver aldehyde oxidaseIdentification and characterization of an antennae-specific aldehyde oxidase from the navel orangewormAllopurinol metabolism in a patient with xanthine oxidase deficiency.Characterization of superoxide production from aldehyde oxidase: an important source of oxidants in biological tissues.The role of molybdenum in human biology.Clinical pharmacokinetics and pharmacodynamics of allopurinol and oxypurinol.Small-interference RNA-mediated knock-down of aldehyde oxidase 1 in 3T3-L1 cells impairs adipogenesis and adiponectin release.Inhibition of xanthine oxidase by the aldehyde oxidase inhibitor raloxifene: implications for identifying molybdopterin nitrite reductasesA novel reaction mediated by human aldehyde oxidase: amide hydrolysis of GDC-0834Human liver aldehyde oxidase: inhibition by 239 drugs.Inborn errors of molybdenum metabolism: combined deficiencies of sulfite oxidase and xanthine dehydrogenase in a patient lacking the molybdenum cofactor.The pneumotoxin 3-methylindole is a substrate and a mechanism-based inactivator of CYP2A13, a human cytochrome P450 enzyme preferentially expressed in the respiratory tract.Inhibitory effects of flavonoids on molybdenum hydroxylases activity.Increasing recognition of the importance of aldehyde oxidase in drug development and discovery.Strategies for a comprehensive understanding of metabolism by aldehyde oxidase.A single nucleotide polymorphism causes enhanced radical oxygen species production by human aldehyde oxidase.Molybdenum-containing nitrite reductases: Spectroscopic characterization and redox mechanism.Non-alcoholic fatty liver disease (NAFLD) - pathogenesis, classification, and effect on drug metabolizing enzymes and transporters.Molybdenum hydroxylases as drug-metabolizing enzymes.Effect of a controlled food-chain mediated exposure to cadmium and arsenic on oxidative enzymes in the tissues of rats.Intracellular localization of aldehyde dehydrogenase in rat liverStructure-based investigation of rat aldehyde oxidase inhibition by flavonoids.Metabolism of 2-nitrofluorene, an environmental pollutant, by liver preparations of sea bream, Pagrus major.Metabolism of zaleplon by human liver: evidence for involvement of aldehyde oxidase.Regulation and biochemistry of mouse molybdo-flavoenzymes. The DBA/2 mouse is selectively deficient in the expression of aldehyde oxidase homologues 1 and 2 and represents a unique source for the purification and characterization of aldehyde oxidaseSimilarity in the aldehyde oxidases from guinea-pig liver and polymorphonuclear leucocytes.Biotransformation of carbazeran in guinea pig: effect of hydralazine pretreatment.Aldehyde oxidase-catalysed oxidation of methotrexate in the liver of guinea-pig, rabbit and man.Species differences in metabolism of ripasudil (K-115) are attributed to aldehyde oxidase.Metabolism of folate antagonists.Influence of farmyard manure on some morphological and biochemical parameters of cowpea (Vigna unguiculata) seedling grown in cadmium-treated soil.Case report of extensive metabolism by aldehyde oxidase in humans: pharmacokinetics and metabolite profile of FK3453 in rats, dogs, and humans.
P2860
Q28328674-CFD3A0B2-475F-419C-88E6-82F6E6874344Q28534187-DCF5D99B-11FD-4021-B75D-F9D0539DCB22Q33554855-ABCAFF00-A3D9-42DF-9A89-D20075F1AB9CQ33815515-5B50504A-C47D-46DF-9B62-800273456C95Q34255009-D734E0ED-6F3E-445B-90B7-0F23DB953663Q34656225-42F8E16F-BD2B-4B82-AF87-43A7DE53927AQ34656848-7F84EE5E-26C6-4ACB-A09E-769E95E2FB12Q34663374-F2DB98D6-BA6E-4CC6-B9B6-A9C1798AD426Q35600249-AFD19C9C-68B1-4585-B79F-2982BA60B656Q35610000-06F652EB-1CC1-4440-9763-6B8900F1C7FFQ36395382-F28B6953-B0A6-4086-B2BD-D9EC616E6F25Q37402748-FA6E4226-5BF9-406E-9235-E4835934E348Q37679897-BFEA7A15-2700-45E8-9482-257AC7FEE7DAQ37856257-AA9BCC2B-1E99-4AE1-A016-7891C16B54BCQ38066611-86303C38-FB79-42C8-9FA7-E022B9C7298EQ38657454-9E43B48F-4ADA-4F3E-A3E1-5147E4A5F214Q38816387-A0260537-B438-40E7-9A76-D29F7D25F6E5Q39183375-8A5BCDC2-33D2-4986-9AB7-E1FC3A5D2336Q39834873-B8B5520B-CF39-4818-952D-BB292463EB92Q41679380-83EDE552-1A9C-42AE-976A-B558ECCBB379Q42160472-F6A8BD01-BDAB-43D7-82B6-6F137030605BQ43645015-6D62A2F7-5207-4B2A-A87C-250B163F96B2Q44150751-DFEFE284-518B-4AA9-8814-3F0033C2FC52Q44206787-8DDDEA98-5B76-4DD7-A0D8-5BE395B49B79Q44686501-98F2AE22-9066-4538-A609-158CA60F4BAFQ46162210-971824BF-4310-4547-8CCC-E866BC1B8D30Q46530308-2A805CB0-1A22-4A13-9FCE-AB277660020DQ46555236-6F1EF044-08BC-48B8-A6CB-A4C931031CF5Q46622705-6E7A20B3-8CBA-49F9-8C2F-4739A241DA9DQ46969807-EF5141D9-63FC-43D4-A6C8-1146C96A1846Q50244516-2894E3AB-7332-47E1-94FC-6B63508EFE9DQ51495569-7C4732F8-FD5A-4349-8905-BA6D1D0E8F25
P2860
Human liver aldehyde oxidase: differential inhibition of oxidation of charged and uncharged substrates
description
1967 nî lūn-bûn
@nan
1967 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
1967 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
1967年の論文
@ja
1967年論文
@yue
1967年論文
@zh-hant
1967年論文
@zh-hk
1967年論文
@zh-mo
1967年論文
@zh-tw
1967年论文
@wuu
name
Human liver aldehyde oxidase: ...... arged and uncharged substrates
@ast
Human liver aldehyde oxidase: ...... arged and uncharged substrates
@en
Human liver aldehyde oxidase: ...... arged and uncharged substrates
@nl
type
label
Human liver aldehyde oxidase: ...... arged and uncharged substrates
@ast
Human liver aldehyde oxidase: ...... arged and uncharged substrates
@en
Human liver aldehyde oxidase: ...... arged and uncharged substrates
@nl
prefLabel
Human liver aldehyde oxidase: ...... arged and uncharged substrates
@ast
Human liver aldehyde oxidase: ...... arged and uncharged substrates
@en
Human liver aldehyde oxidase: ...... arged and uncharged substrates
@nl
P2860
P356
P1476
Human liver aldehyde oxidase: ...... arged and uncharged substrates
@en
P2093
P2860
P304
P356
10.1172/JCI105641
P407
P577
1967-09-01T00:00:00Z